Large-scale dosimetric assessment of Monte Carlo recalculated doses for lung robotic stereotactic body radiation therapy.
For medically inoperable non-small cell lung cancer (NSCLC) patients, stereotactic body radiation therapy (SBRT) has been demonstrated to be a promising treatment alternative. Indeed, as reported in multiple studies [1 –3], the 3-year local control rate of early-stage NSCLC patients treated with SBRT is over 90%. Specifically, increased dose prescribed to the tumor has been shown to be strongly correlated to better local control and survival rates [4]. For adequate lung cancer treatment, it is therefore imperati ve to deliver sufficient and accurate doses to the tumor.
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Veng Jean Heng, Marc-Andr é Renaud, Karim Zerouali, Robert Doucet, André Diamant, Houda Bahig, François DeBlois, Jan Seuntjens Tags: Original paper Source Type: research
More News: Cancer | Cancer & Oncology | General Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Physics | Radiation Therapy | Study